Why Is Corning (GLW) Down 7.4% Since Last Earnings Report? — Negative
GLW Zacks Investment Research — November 27, 2025Corning (GLW) reported earnings 30 days ago. What's next for the stock?
Why Is Group 1 Automotive (GPI) Down 0.3% Since Last Earnings Report? — Neutral
GPI Zacks Investment Research — November 27, 2025Group 1 Automotive (GPI) reported earnings 30 days ago. What's next for the stock?
Incyte (INCY) Up 17.2% Since Last Earnings Report: Can It Continue? — Positive
INCY Zacks Investment Research — November 27, 2025Incyte (INCY) reported earnings 30 days ago. What's next for the stock?
Invesco (IVZ) Up 1.8% Since Last Earnings Report: Can It Continue? — Positive
IVZ Zacks Investment Research — November 27, 2025Invesco (IVZ) reported earnings 30 days ago. What's next for the stock?
Why Is JetBlue (JBLU) Up 10.7% Since Last Earnings Report? — Positive
JBLU Zacks Investment Research — November 27, 2025JetBlue (JBLU) reported earnings 30 days ago. What's next for the stock?
Labcorp (LH) Up 8.1% Since Last Earnings Report: Can It Continue? — Positive
LH Zacks Investment Research — November 27, 2025Labcorp (LH) reported earnings 30 days ago. What's next for the stock?
Why Is IQVIA (IQV) Up 6.4% Since Last Earnings Report? — Positive
IQV Zacks Investment Research — November 27, 2025IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?
PROG: Buy Now, Pay Later Segment May Power P/E Rerate. — Positive
PRG Seeking Alpha — November 27, 2025PROG Holdings, Inc. (PRG) is positioned for a potential P/E rerating as their Buy Now, Pay Later business gains investor attention. Management has $150 million of excess cash from the divestiture of Vive Financial in Q3 2025. PROG repurchases ~1% of outstanding shares every quarter which provides strong downside protection and predictable EPS growth.
Novo Nordisk Seeks Extra-Fast Nod From FDA for Higher Dose of Wegovy — Positive
NVO Zacks Investment Research — November 27, 2025NVO seeks an expedited FDA review for a higher 7.2 mg dose of Wegovy after strong weight-loss results in its STEP UP study.
[Video Enhanced] Dolly Varden Silver CEO Shawn Khunkhun Explains the Impact of the NYSE Listing — Neutral
DVS TheNewswire — November 27, 2025Vancouver, BC – TheNewswire - November 27, 2025 – Global Stocks News - Sponsored content disseminated on behalf of Dolly Varden Silver. Seven months ago, Dolly Varden Silver (TSX-V: DV) (NYSE MKT: DVS) (FSE: DVQ) announced that its shares would begin trading on the New York Stock Exchange (NYSE) under the symbol DVS. At the time, Shawn Khunkhun, President and CEO of Dolly Varden Silver stated, “By listing on the NYSE American, we are gaining access to the world's largest and most liquid equity markets, which we believe will create significant value for our shareholders.”
3 Reasons Why Alibaba Stock May Be a Smart Sell After Q2 Earnings Miss — Negative
BABA Zacks Investment Research — November 27, 2025Alibaba misses Q2 earnings estimates with a 71% profit plunge and negative FCF despite a revenue beat. Its premium valuation versus the industry average signals a sell.
Transaction in Own Shares 27 November, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 27 November, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 27/11/2025 722,180 27.6550 27.4100 27.5232 LSE GBP 27/11/2025 - - - - Chi-X (CXE) GBP 27/11/2025 - - - - BATS (BXE) GBP 27/11/2025 748,014 31.6300 31.4050 …
MOH Deadline: MOH Investors Have Opportunity to Lead Molina Healthcare, Inc. Securities Fraud Lawsuit — Neutral
MOH PRNewsWire — November 27, 2025NEW YORK , Nov. 27, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Molina Healthcare, Inc. (NYSE: MOH) between February 5, 2025 and July 23, 2025, both dates inclusive (the "Class Period"), of the important December 2, 2025 lead plaintiff deadline. So What: If you purchased Molina securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Zacks Initiates Coverage of RYTHM With Underperform Recommendation — Negative
RYM Zacks Investment Research — November 27, 2025Find out why Zacks issues an "Underperform" rating on RYM, being the first on Wall Street to initiate coverage on the stock. Explore how mounting debt, persistent losses and legal disputes cloud the outlook despite a pivot to brand-led, capital-light operations.
Galileo Strengthens SoFi's Fintech Integration and Growth Path — Positive
SOFI Zacks Investment Research — November 27, 2025SOFI leverages Galileo's technology to accelerate innovation, enhance integration and sharpen its fintech edge as its earnings estimates rise.
Intel Rides on Strength in Client Computing Group: Will it Persist? — Positive
INTC Zacks Investment Research — November 27, 2025INTC's Client Computing Group posts an 8% revenue jump as PC upgrades, AI PCs, and new chip demand fuel momentum.
Robotics can 'democratize good healthcare' worldwide: Medtronic CEO — Positive
MDT Fox Business — November 27, 2025Medtronic Chairman and CEO Geoffrey Martha discusses the company's latest robotic innovation and how robotics can impact healthcare on 'The Claman Countdown.' #fox #media #us #usa #new #news #foxbusiness #medtronic #robotics #technology #healthcare #medical #innovation #science #global #economy #business #ai #future #engineering #automation #medicine #healthtech
3 Great Stock ETFs Run by Exceptional Managers — Positive
CGNG OAKM TCAF Morningstar — November 27, 2025Star managers are making the move to ETFs.
ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that aTyr Pharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
ATYR GlobeNewsWire — November 27, 2025NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against aTyr Pharma, Inc. (“aTyr” or “the Company”) (NASDAQ: ATYR) and certain of its officers.
FUN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Six Flags Entertainment Corporation f/k/a CopperSteel HoldCo, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
FUN GlobeNewsWire — November 27, 2025NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed on behalf of purchasers or acquirers of Six Flags Entertainment Corporation f/k/a CopperSteel HoldCo, Inc. (NYSE: FUN) common stock pursuant or traceable to the company's registration statement and prospectus issued in connection with the July 1, 2024 merger of legacy Six Flags Entertainment Corporation (“Legacy Six Flags”) with Cedar Fair, L.P. (“Cedar Fair”), and their subsidiaries and affiliates (the “Merger”).